Looking to sell Valo stock or options?Contact us
Valo, a health tech platform developer, is revolutionizing the drug discovery and development process. By integrating machine learning, cloud computing, and data analysis, Valo's platform examines human data to reveal previously unknown correlations between genetic markers and disease from a human-centric perspective. This innovative approach empowers the healthcare industry to develop drugs for oncology, neurodegenerative, and cardiovascular diseases.
HBM Healthcare Investments, MissionBlue Capital Partners, Atinum Investment, Public Sector Pension Investment Board, E Squared Capital Management, The Invus Group, HBM Partners, Municipal Employees' Retirement System of Michigan, Flagship Pioneering, InterWest Partners, Lanza techVentures, Longevity Vision Fund, Mercury Fund, Mirae Asset Capital, Koch Disruptive Technologies.
We have an even better solution: The Collective Exchange Fund
Get in touch and see if we can help you